MiH

MicroPort Institute of Health (MIH) is a specialized research and development division of MicroPort Scientific Corporation, established to focus on fundamental problems in the health industry and develop total solutions for various diseases. Founded in 2019 and headquartered in Suzhou, China, MIH operates as a core innovation hub that bridges basic biomedical research with large-scale industrialization. The institute manages several basic research platforms and product development centers, with a significant focus on orthopedics, cardiovascular health, and structural heart disease. By leveraging a 'dual circulation' development pattern, MIH provides technical support across the entire industry chain, from initial discovery to technological commercialization. Its expansive facilities in the Suzhou Industrial Park serve as a critical vehicle for facilitating the commercialization of cutting-edge medical technologies and fostering international academic and industrial collaborations.